1
06
AKIMOVA et al.
–
1
EtOH). IR spectrum, ν, cm : 2939, 2860, 1149, 1137,
was then treated according to the general procedure.
Yield 168 mg (70%), white powder, mp 121–123.5°C
1
1
072, 922. H NMR spectrum: δ 1.18–2.11 ppm, m.
C NMR spectrum, δ , ppm: 122.42 (OCO), 42.36
1
3
–1
(from EtOH). IR spectrum, ν, cm : 2956, 2935, 2863,
C
1
(
CH); 32.05, 31.13, 22.40 (CH ). Mass spectrum:
1205, 1190, 1126, 1062, 977, 923. H NMR spectrum,
2
+
m/z 197.1191 [M + H] . C H O . Calculated:
δ, ppm: 0.90–0.91 d (3H, CH ), 1.07–1.90 m (19H).
1
1
16
3
3
1
3
M 196.1099.
,3,16-Trioxatetracyclo[9.4.0.1 .0 ]hexadecane
7). Yield 92%, white plates, mp 118.5–120°C (from
EtOH); published data [2]: mp 119–120°C (from
C NMR spectrum, δ
C
, ppm: 108.24 (OCO); 41.21,
1
,4 4,9
35.51 (CH); 32.92, 28.17, 25.29, 23.86 (CH ); 15.98
2
2
+
(
CH ). Mass spectrum: m/z 239.1643 [M + H] .
3
(
C H O . Calculated: M 238.1569.
1
4
22
3
–
1
MeOH). IR spectrum, ν, cm : 2938, 2857, 1269, 1157,
1
CONFLICT OF INTERESTS
1
1
138, 1066, 972, 923. H NMR spectrum: δ 1.18–
.91 ppm, m. C NMR spectrum, δ , ppm: 108.5
OCO), 41.21 (CH); 32.56, 31.59, 30.75, 25.11, 23.96
CH ). Mass spectrum: m/z 225.1455 [M + H] .
1
3
C
The authors declare the absence of conflict of
interests.
(
(
+
2
C H O . Calculated: M 224.1412
1
3
20
3
REFERENCES
1
,4 4,9
2
,3,15-Trioxatetracyclo[9.3.0.1 .0 ]penta-
–
1
decane (8). Yield 81%, oil. IR spectrum, ν, cm :
1. Akimova, T.I. and Soldatkina, O.A., RU Patent
1
2
940, 2867, 1446, 1349, 1099, 1045, 928. H NMR
no. 2578609, 2016; Byull. Izobret., 2016, no. 9.
2. Kondelikova, J., Kralicek, J., and Kubanek, V., Collect.
Czech. Chem. Commun., 1972, vol. 37, p. 263.
1
3
spectrum: δ 1.18–2.1 ppm, m. C NMR spectrum, δ ,
C
ppm: 123.62, 111.21 (OCO); 47.79, 43.57 (CH);
3
4.52, 34.15, 33.43, 32.52, 30.44, 25.58, 23.66, 22.58
3. Gomes, G.P., Yaremenko, I.A., Radulov, P.S.,
Novikov, R.A., Chernyshev, V.V., Korlyukov, A.A.,
Nikishin, G.I., Alabugin, I.V., and Terent’ev, A.O.,
Angew. Chem., Int. Ed., 2017, vol. 56, p. 4955.
+
(
CH ). Mass spectrum: m/z 211.1352 [M + H] .
2
C H O . Calculated: M 210.1256.
1
2
18
3
1
,4 4,10
2
,3,17-Trioxatetracyclo[10.4.0.1 .0 ]hepta-
4
5
6
. Yaremenko, I.A., Gomes, G.P., Radulov, P.S.,
Belyakova, Yu.Yu., Vilikotskiy, A.E., Vil’, V.A.,
Korlyukov, A.A., Nikishin, G.I., Alabugin, I.V., and
Terent’ev, A.O., J. Org. Chem., 2018, vol. 83, p. 4402.
. Yaremenko, I.A., Terent’ev, A.O., Vil’, V.A.,
Novikov, R.A., Chernyshev, V.V., Tafeenko, V.A.,
Levitsky, D.O., Fleury, F., and Nikishin, G.I., Chem.
Eur. J., 2014, vol. 20, p. 10160.
decane (9). Diketone 4, 100 mg (0.45 mmol), was
dissolved in 2 mL of ethanol, 0.2 mL (1.64 mmol)
of 30% aqueous hydrogen peroxide and a drop of
3
3% H SO (0.4 mmol) were added, and the mixture
2 4
was left to stand for 12 h at room temperature. The
product was isolated according to the general proce-
dure (see above). Yield 60 mg (56%), needles, mp 60–
6
1
–
1
1°C (from EtOH). IR spectrum, ν, cm : 2938, 2858,
. Criegee, R. and Lohaus, G., Chem. Ber., 1953, vol. 86,
1
157, 1138, 1066, 967, 923. H NMR spectrum:
p. 1.
1
3
δ 1.18–1.91 ppm, m. C NMR spectrum, δ , ppm:
C
7. Griesbaum, K., Liu, X., and Dong, Y., Tetrahedron,
1
3
12.8, 109.6 (OCO); 44.89, 41.50 (CH); 35.99, 33.11,
1997, vol. 53, p. 5463.
. Griesbaum, K., Liu, X., Kassiaris, A., and Scherer, M.,
Justus Liebigs Ann. Chem., 1997, p. 1381.
2.34, 30.36, 30.15, 30.15, 29.06, 25.10, 23.89, 22.53
8
+
(
CH ). Mass spectrum: m/z 239.1612 [M + H] .
2
C H O . Calculated: M 238.1569
1
4
22
3
9. Barton, V., Ward, S.A., Chadwick, J., Hill, A., and
1
,4 4,9
O’Neill, P.M., J. Med. Chem., 2010, vol. 53, p. 4555.
1
0-Methyl-2,3,16-trioxatetracyclo[9.4.0.1 .0 ]-
1
1
0. Dong, Y., Chollet, J., Matile, H., Charman, S.A.,
Chiu, F.C.K., Charman, W.N., Scorneaux, B.,
Urwyler, H., Tomas, J.S., Scheurer, C., Snyder, C.,
Dorn, A., Wang, X., Karle, J.M., Tang, Y., Wittlin, S.,
Brun, R., and Vennerstrom, J.L., J. Med. Chem., 2005,
vol. 48, p. 4953.
1. Dong, Y., Wittlin, S., Sriraghavan, K., Chollet, J.,
Charman, S.A., Charman, W.N., Scheurer, C.,
Urwyler, H., Tomas, J.S., Snyder, C., Creek, D.J.,
Morizzi, J., Koltun, M., Matile, H., Wang, X.,
Padmanilayam, M., Tang, Y., Dorn, A., Brun, R., and
Vennerstrom, J.L., J. Med. Chem., 2010, vol. 53, p. 481.
hexadecane (10). Ketol 5a, 200 mg (0.9 mmol), was
melted at 180–186°C on a metal bath and was kept for
3
0 min at that temperature. Diketone 5 thus obtained
was dissolved in 2 mL of diethyl ether, and the
undissolved material (ketol 5a, 44 mg) was filtered off.
The filtrate was placed in an ice bath, 0.18 mL
(
15 mmol) of 30% aqueous hydrogen peroxide was
added, and a solution of 0.15 mL (1 mmol) of boron
trifluoride–diethyl ether complex in 2 mL of diethyl
ether was added dropwise, maintaining the temperature
at 0°C. The mixture was stirred for 12 h at 20°C and
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 55 No. 1 2019